NCT05123521

Brief Summary

Drug abusers and addicts form a challenge to the anesthetist because of the added potential risks involved in the administration of anesthesia to this subset of patients, including potential unforeseen drug-drug interactions. In this study, we aimed at screening all patients scheduled for elective orthopedic or general surgeries at the Cairo University Teaching Hospital during a set period of time for the most commonly abused drugs in Egypt.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2019

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

October 23, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 17, 2021

Completed
Last Updated

November 17, 2021

Status Verified

November 1, 2021

Enrollment Period

6 months

First QC Date

October 23, 2021

Last Update Submit

November 5, 2021

Conditions

Keywords

drug abuseCairo Teaching Hospitalelective surgery

Outcome Measures

Primary Outcomes (1)

  • urine analysis

    multi-drug screen panel dip steak (Abon Biopharm (Hangzhou) , Ltd)

    THREE MONTHS

Interventions

urine analysisDIAGNOSTIC_TEST

Urine was then tested for evidence of substance abuse using the multi-drug screen panel dip steak ABONtm (Abon Biopharm (Hangzhou) CO., Ltd) which is a lateral flow chromatographic immunoassay . It allowed for qualitative detection of multiple drugs in a single run. This kit was chosen for its ability to detect the most commonly abused substances in Egypt, namely: opioids, benzodiazepines, hashish, and tramadol. A single coloured line at region C for of a specific drug indicated a positive result, whilst two coloured lines at both regions C and T indicated a negative result. The absence of coloured lines was an indication of the invalidity of the particular kit, and the kit was discarded.

Eligibility Criteria

Age15 Years - 60 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

those who had presented to the General Surgery or Orthopaedics Departments

You may qualify if:

  • male or female patients classified as American Society of Anaesthesiology (ASA) I or II patients
  • patients between 15 and 60 years of age
  • patients scheduled for elective surgery.

You may not qualify if:

  • emergency surgery
  • those with disturbed conscious levels
  • history of psychological illness
  • who refused to give consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Giza Governorate, 1234, Egypt

Location

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Urinalysis

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Clinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, UrologicalInvestigative Techniques

Study Officials

  • Hassan Ali, Md

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate prof

Study Record Dates

First Submitted

October 23, 2021

First Posted

November 17, 2021

Study Start

August 1, 2018

Primary Completion

January 28, 2019

Study Completion

February 28, 2019

Last Updated

November 17, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations